INR Advisory Services’s AbbVie ABBV Stock Holding History

INR Advisory Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$46K	Sell	573 -125	-18%	-$10.2K	0.01%	31
2018 Q4	$64K	Hold	698	–	–	0.01%	25
2018 Q3	$66K	Hold	698	–	–	0.01%	20
2018 Q2	$65K	Hold	698	–	–	0.01%	21
2018 Q1	$66K	Hold	698	–	–	0.01%	20
2017 Q4	$68K	Hold	698	–	–	0.01%	19
2017 Q3	$62K	Hold	698	–	–	0.01%	20
2017 Q2	$51K	Sell	698 -294	-30%	-$19.8K	0.01%	21
2017 Q1	$65K	Hold	992	–	–	0.01%	29
2016 Q4	$62K	Sell	992 -205	-17%	-$12.5K	0.01%	28
2016 Q3	$75K	Hold	1,197	–	–	0.01%	27
2016 Q2	$74K	Buy	+1,197	New	+$72.9K	0.01%	26

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

INR Advisory Services's ABBV Position: Q1 2019 in Review

INR Advisory Services reduced its AbbVie (ABBV) stake by 18% in Q1 2019, selling an estimated $10.2K and leaving 573 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #31.

INR Advisory Services first reported a position in ABBV in Q2 2016 and has held it in 12 quarters since. The position peaked at $75K in Q3 2016. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

INR Advisory Services held 573 shares of AbbVie worth $46K as of Q1 2019.
INR Advisory Services sold 125 AbbVie shares in Q1 2019, an estimated $10.2K.
AbbVie made up 0.01% of INR Advisory Services's portfolio in Q1 2019, its #31 holding.
INR Advisory Services first reported a position in AbbVie in Q2 2016 and has held it in 12 quarters since.
INR Advisory Services's AbbVie position peaked at $75K in Q3 2016.
2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on INR Advisory Services's 13F filing for Q1 2019, filed 22 Apr 2019.